Seeing Is Believing
with an average price target of $33.63. This is a potential upside of $2.4 (7.68%) from yesterday's end of day stock price of $31.23.
ImmunoGen's activity chart (see below) currently has 94 price targets and 88 ratings on display.
Analysts average stock forecasts to be materialized ratio is 94.74% with an average time for these price targets to be met of 547.26 days.
Most recent stock forecast was given by PETER LAWSON from BARCLAYS on 03-Dec-2023. First documented stock forecast 06-Aug-2012.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$27
$-4.23 (-13.54%)
$27
1 years 10 months 4 days ago
(03-Dec-2023)
3/4 (75%)
$-2.22 (-7.60%)
175
Hold
$31
$-0.23 (-0.74%)
$12
1 years 10 months 6 days ago
(01-Dec-2023)
2/2 (100%)
$1.68 (5.73%)
294
Hold
$24
$-7.23 (-23.15%)
$6
1 years 10 months 7 days ago
(30-Nov-2023)
5/6 (83.33%)
$-5.32 (-18.14%)
721
Hold
$25
$-6.23 (-19.95%)
1 years 10 months 7 days ago
(30-Nov-2023)
3/4 (75%)
$-4.32 (-14.73%)
677
Hold
$18
1 years 10 months 7 days ago
(30-Nov-2023)
2/2 (100%)
$2.85 (18.81%)
86
What is IMGN (ImmunoGen) average time for price targets to be met?
Which analyst has the current highest performing score on IMGN (ImmunoGen) with a proven track record?
Which analyst has the most public recommendations on IMGN (ImmunoGen)?
Which analyst is the currently most bullish on IMGN (ImmunoGen)?
Which analyst is the currently most reserved on IMGN (ImmunoGen)?